Home / Health / New TB Test Promises Cheaper, Faster Diagnosis
New TB Test Promises Cheaper, Faster Diagnosis
6 Mar
Summary
- WHO endorses affordable molecular TB tests for primary care.
- Tongue swabs offer an alternative to sputum for sample collection.
- The new test costs $3.50, significantly cheaper than previous options.
A significant advancement in tuberculosis testing has been announced, with the World Health Organization (WHO) endorsing a new class of near-point-of-care molecular tests (NPOC-NAATs). These tests are designed for initial TB detection and can be implemented at the primary care level, offering a more affordable and accessible diagnostic solution.
Professor Madhukar Pai of McGill University highlighted the policy's importance, noting that these tests are more cost-effective than existing molecular options. The WHO also supports the use of tongue swabs as an easy-to-collect specimen for individuals unable to provide sputum, a common challenge, particularly for infants and children.
These new tests are available through the Global Drug Facility for $3.50 each. Experts suggest a potential for widespread adoption, with several countries planning rollout through Global Fund programs. This initiative aims to bridge diagnostic gaps and ensure timely treatment for TB patients worldwide.
